Skip to main content

First Taxotere Bellwether Trial Postponed To September 2019

First Taxotere Bellwether Trial Postponed To September 2019

First Taxotere Bellwether Trial Postponed To September 2019

Introduction

In a case management order issued on March 22, U.S. District Judge Jane Triche Milazzo, presiding over all Taxotere hair loss lawsuits, indicated that the start of the first bellwether trial was delayed until September 16, 2019.

The first five bellwether cases were scheduled to go before the jury on May 13, 2019, and additional cases were scheduled for September 16, 2019; January 27, 2020; May 11, 2020; and September 14, 2020. Taxotere manufacturer Sanofi-Aventis faces some 12,000 product liability claims that it failed to warn about the risks of hair loss from its breast cancer drug, Taxotere, which is not the case with other, equally effective, breast cancer treatments. Though hair loss is a possible side effect of chemotherapy, the lawsuits blamed Sanofi-Aventis of providing misleading information that the patient's hair would regrow after the treatment. However, Taxotere has been reported to cause permanent thinning and balding even long after the treatments are over.

Taxotere lawsuits were centralized in the Eastern District of Louisiana, as part of a federal Multidistrict Litigation, or MDL (MDL No. 2740; In Re: Taxotere (Docetaxel) Products Liability Litigation).

Comments

Restricted HTML

  • Allowed HTML tags: <a href hreflang> <em> <strong> <cite> <blockquote cite> <code> <ul type> <ol start type> <li> <dl> <dt> <dd> <h2 id> <h3 id> <h4 id> <h5 id> <h6 id>
  • Lines and paragraphs break automatically.
  • Web page addresses and email addresses turn into links automatically.

Latest News

First Federal Bellwether Trial Set in Strattice Mesh Case

Categories: Hernia Mesh

Lawyers involved in federal Strattice hernia mesh litigation are scheduled to meet with the presiding judge in the U.S. District Court for the District of New Jersey to…

Tepezza Hearing Loss Trial Set for June 2026

Categories: Tepezza

The U.S. District Judge overseeing all federal Tepezza lawsuits has postponed the start of the first bellwether trial by 60 days.

This decision comes as attorneys…

FDA Moves to Restrict Dangerous 7-OH Opioid Products

Categories: Opioids

In a significant move to combat the ongoing opioid crisis, the U.S. Food and Drug Administration (FDA) has recommended a scheduling action under the Controlled Substances Act (CSA) to regulate certain products containing 7-hydroxymitragynine (7-…

✍️ FREE — 2,800 Pages Legal Process Outsourcing Trial!                 
No Contract. No Risk — Full Mass Tort + LPO Access, Free!

Only 10 Firms Accepted—Offer Ends August 31!